Methylpropylpropanediol dinitrate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Methylpropylpropanediol dinitrate
Accession Number
DB13408
Description
Not Available
Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 222.197
Monoisotopic: 222.085186179
Chemical Formula
C7H14N2O6
Synonyms
  • 2-methyl-2-propylpropane-1,3-diyl dinitrate

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication
Not Available
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AmiodaroneAmiodarone may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
AmlodipineAmlodipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
AvanafilThe risk or severity of hypotension can be increased when Avanafil is combined with Methylpropylpropanediol dinitrate.
BepridilBepridil may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
CarvedilolCarvedilol may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
CinnarizineCinnarizine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
ClevidipineClevidipine may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
CyclandelateCyclandelate may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
DiltiazemDiltiazem may increase the vasodilatory activities of Methylpropylpropanediol dinitrate.
DipyridamoleThe risk or severity of hypotension can be increased when Dipyridamole is combined with Methylpropylpropanediol dinitrate.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Categories

ATC Codes
C01DA54 — Methylpropylpropanediol dinitrate, combinationsC01DA04 — Methylpropylpropanediol dinitrate
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as alkyl nitrates. These are organic compounds containing a nitrate that is O-linked to an alkyl group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organic oxoanionic compounds
Sub Class
Organic nitrates
Direct Parent
Alkyl nitrates
Alternative Parents
Organic nitro compounds / Organic nitric acids and derivatives / Organooxygen compounds / Organic oxides / Organic nitrogen compounds / Hydrocarbon derivatives
Substituents
Aliphatic acyclic compound / Alkyl nitrate / Allyl-type 1,3-dipolar organic compound / Hydrocarbon derivative / Organic 1,3-dipolar compound / Organic nitric acid or derivatives / Organic nitro compound / Organic nitrogen compound / Organic oxide / Organooxygen compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
Not Available

Chemical Identifiers

UNII
C317706XA7
CAS number
10605-24-0
InChI Key
BLJBDLGFKNXUCB-UHFFFAOYSA-N
InChI
InChI=1S/C7H14N2O6/c1-3-4-7(2,5-14-8(10)11)6-15-9(12)13/h3-6H2,1-2H3
IUPAC Name
2-methyl-1-(nitrooxy)-2-[(nitrooxy)methyl]pentane
SMILES
CCCC(C)(CO[N+]([O-])=O)CO[N+]([O-])=O

References

General References
Not Available
ChemSpider
23742

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.153 mg/mLALOGPS
logP2.3ALOGPS
logP2.11ChemAxon
logS-3.2ALOGPS
pKa (Strongest Basic)-5.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area104.74 Å2ChemAxon
Rotatable Bond Count8ChemAxon
Refractivity48.76 m3·mol-1ChemAxon
Polarizability20.34 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created on June 23, 2017 20:41 / Updated on June 12, 2020 16:53